-
1
-
-
84855966142
-
Phosphate: The new cholesterol? The role of the phosphate axis in non-uremic vascular disease
-
Ellam TJ, Chico TJ: Phosphate: The new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220: 310-318, 2012
-
(2012)
Atherosclerosis
, vol.220
, pp. 310-318
-
-
Ellam, T.J.1
Chico, T.J.2
-
2
-
-
34248522825
-
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
-
DOI 10.1001/archinte.167.9.879
-
Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885, 2007 (Pubitemid 46762749)
-
(2007)
Archives of Internal Medicine
, vol.167
, Issue.9
, pp. 879-885
-
-
Dhingra, R.1
Sullivan, L.M.2
Fox, C.S.3
Wang, T.J.4
D'Agostino Sr., R.B.5
Gaziano, J.M.6
Vasan, R.S.7
-
3
-
-
0034836578
-
4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
-
Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001 (Pubitemid 32880350)
-
(2001)
Journal of the American Society of Nephrology
, vol.12
, Issue.10
, pp. 2131-2138
-
-
Ganesh, S.K.1
Stack, A.G.2
Levin, N.W.3
Hulbert-Shearon, T.4
Port, F.K.5
-
4
-
-
0031920748
-
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
-
Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31: 607-617, 1998
-
(1998)
Am J Kidney Dis
, vol.31
, pp. 607-617
-
-
Block, G.A.1
Hulbert-Shearon, T.E.2
Levin, N.W.3
Port, F.K.4
-
5
-
-
78650322250
-
Serum phosphate and mortality in patients with chronic kidney disease
-
Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, Hegarty J, New J, O'Donoghue DJ, Middleton RJ, Kalra PA: Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 2251-2257, 2010
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 2251-2257
-
-
Eddington, H.1
Hoefield, R.2
Sinha, S.3
Chrysochou, C.4
Lane, B.5
Foley, R.N.6
Hegarty, J.7
New, J.8
O'Donoghue, D.J.9
Middleton, R.J.10
Kalra, P.A.11
-
6
-
-
20544433192
-
Serum phosphate levels and mortality risk among people with chronic kidney disease
-
DOI 10.1681/ASN.2004070602
-
Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005 (Pubitemid 41725150)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.2
, pp. 520-528
-
-
Kestenbaum, B.1
Sampson, J.N.2
Rudser, K.D.3
Patterson, D.J.4
Seliger, S.L.5
Young, B.6
Sherrard, D.J.7
Andress, D.L.8
-
7
-
-
63049135405
-
Serum phosphorus and cardiovascular mortality in type 2 diabetes
-
Chonchol M, Dale R, Schrier RW, Estacio R: Serum phosphorus and cardiovascular mortality in type 2 diabetes. Am J Med 122: 380-386, 2009
-
(2009)
Am J Med
, vol.122
, pp. 380-386
-
-
Chonchol, M.1
Dale, R.2
Schrier, R.W.3
Estacio, R.4
-
8
-
-
27444436252
-
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
-
DOI 10.1161/CIRCULATIONAHA.105.553198
-
Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol And Recurrent Events Trial Investigators: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005 (Pubitemid 41532599)
-
(2005)
Circulation
, vol.112
, Issue.17
, pp. 2627-2633
-
-
Tonelli, M.1
Sacks, F.2
Pfeffer, M.3
Gao, Z.4
Curhan, G.5
-
9
-
-
66149157312
-
Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA
-
Ix JH, De Boer IH, Peralta CA, Adeney KL, Duprez DA, Jenny NS, Siscovick DS, Kestenbaum BR: Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol 4: 609-615, 2009
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 609-615
-
-
Ix, J.H.1
De Boer, I.H.2
Peralta, C.A.3
Adeney, K.L.4
Duprez, D.A.5
Jenny, N.S.6
Siscovick, D.S.7
Kestenbaum, B.R.8
-
10
-
-
84555187981
-
Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: A cardiac magnetic resonance study
-
Chue CD, Edwards NC, Moody WE, Steeds RP, Townend JN, Ferro CJ: Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: A cardiac magnetic resonance study. Heart 98: 219-224, 2012
-
(2012)
Heart
, vol.98
, pp. 219-224
-
-
Chue, C.D.1
Edwards, N.C.2
Moody, W.E.3
Steeds, R.P.4
Townend, J.N.5
Ferro, C.J.6
-
11
-
-
77955448555
-
Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community
-
Dhingra R, Gona P, Benjamin EJ, Wang TJ, Aragam J, D'Agostino RB Sr, Kannel WB, Vasan RS: Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 12: 812-818, 2010
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 812-818
-
-
Dhingra, R.1
Gona, P.2
Benjamin, E.J.3
Wang, T.J.4
Aragam, J.5
D'Agostino Sr., R.B.6
Kannel, W.B.7
Vasan, R.S.8
-
12
-
-
60449096473
-
Serum phosphate and left ventricular hypertrophy in young adults: The coronary artery risk development in young adults study
-
Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA: Serum phosphate and left ventricular hypertrophy in young adults: The coronary artery risk development in young adults study. Kidney Blood Press Res 32: 37-44, 2009
-
(2009)
Kidney Blood Press Res
, vol.32
, pp. 37-44
-
-
Foley, R.N.1
Collins, A.J.2
Herzog, C.A.3
Ishani, A.4
Kalra, P.A.5
-
13
-
-
79957870135
-
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
-
Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M: Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79: 1370-1378, 2011
-
(2011)
Kidney Int
, vol.79
, pp. 1370-1378
-
-
Isakova, T.1
Wahl, P.2
Vargas, G.S.3
Gutiérrez, O.M.4
Scialla, J.5
Xie, H.6
Appleby, D.7
Nessel, L.8
Bellovich, K.9
Chen, J.10
Hamm, L.11
Gadegbeku, C.12
Horwitz, E.13
Townsend, R.R.14
Anderson, C.A.15
Lash, J.P.16
Hsu, C.Y.17
Leonard, M.B.18
Wolf, M.19
-
14
-
-
34047103452
-
Mineral metabolism parameters throughout chronic kidney disease stages 1-5 - Achievement of K/DOQI target ranges
-
DOI 10.1093/ndt/gfl718
-
Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E: Mineral metabolism parameters throughout chronic kidney disease stages 1-5 - achievement of K/DOQI target ranges. Nephrol Dial Transplant 22: 1171-1176, 2007 (Pubitemid 46523434)
-
(2007)
Nephrology Dialysis Transplantation
, vol.22
, Issue.4
, pp. 1171-1176
-
-
Craver, L.1
Marco, M.P.2
Martinez, I.3
Rue, M.4
Borras, M.5
Martin, M.L.6
Sarro, F.7
Valdivielso, J.M.8
Fernandez, E.9
-
15
-
-
80555148939
-
FGF23 induces left ventricular hypertrophy
-
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-OM, Kusek JW, Keane MG, Wolf M: FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393 -4408, 2011
-
(2011)
J Clin Invest
, vol.121
, pp. 4393-4408
-
-
Faul, C.1
Amaral, A.P.2
Oskouei, B.3
Hu, M.C.4
Sloan, A.5
Isakova, T.6
Gutiérrez, O.M.7
Aguillon-Prada, R.8
Lincoln, J.9
Hare, J.M.10
Mundel, P.11
Morales, A.12
Scialla, J.13
Fischer, M.14
Soliman, E.Z.15
Chen, J.16
Go, A.S.17
Rosas, S.E.18
Nessel, L.19
Townsend, R.R.20
Feldman, H.I.21
St John Sutton, M.22
Ojo, A.23
Gadegbeku, C.24
Di Marco, G.S.25
Reuter, S.26
Kentrup, D.27
Tiemann, K.28
Brand, M.29
Hill, J.A.30
Moe, O.W.31
Kuro, O.M.32
Kusek, J.W.33
Keane, M.G.34
Wolf, M.35
more..
-
16
-
-
77953713676
-
Arterial stiffness in chronic kidney disease: Causes and consequences
-
Chue CD, Townend JN, Steeds RP, Ferro CJ: Arterial stiffness in chronic kidney disease: Causes and consequences. Heart 96: 817-823, 2010
-
(2010)
Heart
, vol.96
, pp. 817-823
-
-
Chue, C.D.1
Townend, J.N.2
Steeds, R.P.3
Ferro, C.J.4
-
17
-
-
33745852282
-
Chronic kidney disease and mortality risk: A systematic review
-
DOI 10.1681/ASN.2005101085
-
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047, 2006 (Pubitemid 44036188)
-
(2006)
Journal of the American Society of Nephrology
, vol.17
, Issue.7
, pp. 2034-2047
-
-
Tonelli, M.1
Wiebe, N.2
Culleton, B.3
House, A.4
Rabbat, C.5
Fok, M.6
McAlister, F.7
Garg, A.X.8
-
18
-
-
0033977863
-
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension
-
Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F: Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 35: 580-586, 2000 (Pubitemid 30108152)
-
(2000)
Hypertension
, vol.35
, Issue.2
, pp. 580-586
-
-
Schillaci, G.1
Verdecchia, P.2
Porcellati, C.3
Cuccurullo, O.4
Cosco, C.5
Perticone, F.6
-
19
-
-
0028939185
-
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
-
Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
-
(1995)
Kidney Int
, vol.47
, pp. 186-192
-
-
Foley, R.N.1
Parfrey, P.S.2
Harnett, J.D.3
Kent, G.M.4
Martin, C.J.5
Murray, D.C.6
Barre, P.E.7
-
20
-
-
70350244426
-
Is lowering phosphate exposure the key to preventing arterial stiffening with age?
-
Ferro CJ, Chue CD, Steeds RP, Townend JN: Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart 95: 1770-1772, 2009
-
(2009)
Heart
, vol.95
, pp. 1770-1772
-
-
Ferro, C.J.1
Chue, C.D.2
Steeds, R.P.3
Townend, J.N.4
-
21
-
-
59949091183
-
Serum phosphorus levels associate with coronary atherosclerosis in young adults
-
Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA: Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20: 397-404, 2009
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 397-404
-
-
Foley, R.N.1
Collins, A.J.2
Herzog, C.A.3
Ishani, A.4
Kalra, P.A.5
-
22
-
-
73649107226
-
Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function
-
Tuttle KR, Short RA: Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function. Clin J Am Soc Nephrol 4: 1968-1973, 2009
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 1968-1973
-
-
Tuttle, K.R.1
Short, R.A.2
-
23
-
-
59949102335
-
Association of serum phosphate with vascular and valvular calcification in moderate CKD
-
Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20: 381-387, 2009
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 381-387
-
-
Adeney, K.L.1
Siscovick, D.S.2
Ix, J.H.3
Seliger, S.L.4
Shlipak, M.G.5
Jenny, N.S.6
Kestenbaum, B.R.7
-
24
-
-
67649739089
-
Dietary phosphorus acutely impairs endothelial function
-
Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E: Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 20: 1504-1512, 2009
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1504-1512
-
-
Shuto, E.1
Taketani, Y.2
Tanaka, R.3
Harada, N.4
Isshiki, M.5
Sato, M.6
Nashiki, K.7
Amo, K.8
Yamamoto, H.9
Higashi, Y.10
Nakaya, Y.11
Takeda, E.12
-
25
-
-
0034730291
-
Phosphate regulation of vascular smooth muscle cell calcification
-
Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17, 2000
-
(2000)
Circ Res
, vol.87
-
-
Jono, S.1
McKee, M.D.2
Murry, C.E.3
Shioi, A.4
Nishizawa, Y.5
Mori, K.6
Morii, H.7
Giachelli, C.M.8
-
26
-
-
0342588049
-
Arterial stiffening and vascular calcifications in end-stage renal disease
-
Guérin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15: 1014-1021, 2000 (Pubitemid 30410374)
-
(2000)
Nephrology Dialysis Transplantation
, vol.15
, Issue.7
, pp. 1014-1021
-
-
Guerin, A.P.1
London, G.M.2
Marchais, S.J.3
Metivier, F.4
-
27
-
-
61749086214
-
Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals
-
Anglo-Cardiff Collaboration Trial Investigators
-
McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, Hickson SS, Yasmin, Maki-Petaja KM, Cockcroft JR, Dixon AK, Wilkinson IB; Anglo-Cardiff Collaboration Trial Investigators: Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension 53: 524-531, 2009
-
(2009)
Hypertension
, vol.53
, pp. 524-531
-
-
McEniery, C.M.1
McDonnell, B.J.2
So, A.3
Aitken, S.4
Bolton, C.E.5
Munnery, M.6
Hickson, S.S.7
Yasmin8
Maki-Petaja, K.M.9
Cockcroft, J.R.10
Dixon, A.K.11
Wilkinson, I.B.12
-
28
-
-
34247204360
-
Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients
-
DOI 10.1038/sj.ki.5002164, PII 5002164
-
Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA: Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 71: 802-807, 2007 (Pubitemid 46624028)
-
(2007)
Kidney International
, vol.71
, Issue.8
, pp. 802-807
-
-
Raggi, P.1
Bellasi, A.2
Ferramosca, E.3
Islam, T.4
Muntner, P.5
Block, G.A.6
-
29
-
-
33845241514
-
Left ventricular hypertrophy: Is hyperphosphatemia among dialysis patients a risk factor?
-
DOI 10.1681/ASN.2006080923
-
Achinger SG, Ayus JC: Left ventricular hypertrophy: Is hyperphosphatemia among dialysis patients a risk factor? J Am Soc Nephrol 17[Suppl 3]: S255-S261, 2006 (Pubitemid 44865258)
-
(2006)
Journal of the American Society of Nephrology
, vol.17
, Issue.SUPPL. 3
-
-
Achinger, S.G.1
Ayus, J.C.2
-
30
-
-
34547443884
-
Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption
-
DOI 10.1073/pnas.0704446104
-
Berndt T, Thomas LF, Craig TA, Sommer S, Li X, Bergstralh EJ, Kumar R: Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A 104: 11085-11090, 2007 (Pubitemid 47175230)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.26
, pp. 11085-11090
-
-
Berndt, T.1
Thomas, L.F.2
Craig, T.A.3
Sommer, S.4
Li, X.5
Bergstralh, E.J.6
Kumar, R.7
-
31
-
-
84864859705
-
Effects of phosphate binders in moderate CKD
-
Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM: Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23: 1407-1415, 2012
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 1407-1415
-
-
Block, G.A.1
Wheeler, D.C.2
Persky, M.S.3
Kestenbaum, B.4
Ketteler, M.5
Spiegel, D.M.6
Allison, M.A.7
Asplin, J.8
Smits, G.9
Hoofnagle, A.N.10
Kooienga, L.11
Thadhani, R.12
Mannstadt, M.13
Wolf, M.14
Chertow, G.M.15
-
32
-
-
0033574249
-
A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
-
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999 (Pubitemid 29135798)
-
(1999)
Annals of Internal Medicine
, vol.130
, Issue.6
, pp. 461-470
-
-
Levey, A.S.1
Bosch, J.P.2
Lewis, J.B.3
Greene, T.4
Rogers, N.5
Roth, D.6
-
33
-
-
67651048925
-
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: A randomized controlled trial
-
Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN: Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: A randomized controlled trial. J Am Coll Cardiol 54: 505-512, 2009
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 505-512
-
-
Edwards, N.C.1
Steeds, R.P.2
Stewart, P.M.3
Ferro, C.J.4
Townend, J.N.5
-
34
-
-
0036199613
-
Assessment of left ventricular mass by cardiovascular magnetic resonance
-
DOI 10.1161/hy0302.104674
-
Myerson SG, Bellenger NG, Pennell DJ: Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39: 750-755, 2002 (Pubitemid 34252869)
-
(2002)
Hypertension
, vol.39
, Issue.3
, pp. 750-755
-
-
Myerson, S.G.1
Bellenger, N.G.2
Pennell, D.J.3
-
35
-
-
84863115528
-
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial
-
Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD: Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial. JAMA 307: 674-684, 2012
-
(2012)
JAMA
, vol.307
, pp. 674-684
-
-
Thadhani, R.1
Appelbaum, E.2
Pritchett, Y.3
Chang, Y.4
Wenger, J.5
Tamez, H.6
Bhan, I.7
Agarwal, R.8
Zoccali, C.9
Wanner, C.10
Lloyd-Jones, D.11
Cannata, J.12
Thompson, B.T.13
Andress, D.14
Zhang, W.15
Packham, D.16
Singh, B.17
Zehnder, D.18
Shah, A.19
Pachika, A.20
Manning, W.J.21
Solomon, S.D.22
more..
-
36
-
-
34848862734
-
How should we measure medication adherence in clinical trials and practice?
-
Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ, Turner PT, Sullenberger LE, Taylor AJ: How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag 3: 685-690, 2007 (Pubitemid 47496971)
-
(2007)
Therapeutics and Clinical Risk Management
, vol.3
, Issue.4
, pp. 685-690
-
-
Lee, J.K.1
Grace, K.A.2
Foster, T.G.3
Crawley, M.J.4
Erowele, G.I.5
Sun, H.J.6
Turner, P.T.7
Sullenberger, L.E.8
Taylor, A.J.9
-
37
-
-
0025345588
-
Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials
-
Muldoon MF, Manuck SB, Matthews KA: Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. BMJ 301: 309-314, 1990 (Pubitemid 20238057)
-
(1990)
British Medical Journal
, vol.301
, Issue.6747
, pp. 309-314
-
-
Muldoon, M.F.1
Manuck, S.B.2
Matthews, K.A.3
-
38
-
-
9344242932
-
Coronary artery calcification in patients with CRF not undergoing dialysis
-
DOI 10.1053/j.ajkd.2004.07.022, PII S0272638604012594
-
Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE: Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44: 1024-1030, 2004 (Pubitemid 39556482)
-
(2004)
American Journal of Kidney Diseases
, vol.44
, Issue.6
, pp. 1024-1030
-
-
Russo, D.1
Palmiero, G.2
De Blasio, A.P.3
Balletta, M.M.4
Andreucci, V.E.5
-
39
-
-
79951775260
-
Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients
-
Kakuta T, Tanaka R, Hyodo T, Suzuki H, Kanai G, Nagaoka M, Takahashi H, Hirawa N, Oogushi Y, Miyata T, Kobayashi H, Fukagawa M, Saito A: Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis 57: 422-431, 2011
-
(2011)
Am J Kidney Dis
, vol.57
, pp. 422-431
-
-
Kakuta, T.1
Tanaka, R.2
Hyodo, T.3
Suzuki, H.4
Kanai, G.5
Nagaoka, M.6
Takahashi, H.7
Hirawa, N.8
Oogushi, Y.9
Miyata, T.10
Kobayashi, H.11
Fukagawa, M.12
Saito, A.13
-
40
-
-
0036310682
-
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
-
DOI 10.1046/j.1523-1755.2002.00434.x
-
Chertow GM, Burke SK, Raggi P; Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252, 2002 (Pubitemid 34754068)
-
(2002)
Kidney International
, vol.62
, Issue.1
, pp. 245-252
-
-
Chertow, G.M.1
Burke, S.K.2
Raggi, P.3
-
41
-
-
0030746379
-
Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease
-
DOI 10.1016/S0167-5273(97)02971-9, PII S0167527397029719
-
Narang R, Ridout D, Nonis C, Kooner JS: Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60: 73-79, 1997 (Pubitemid 27288259)
-
(1997)
International Journal of Cardiology
, vol.60
, Issue.1
, pp. 73-79
-
-
Narang, R.1
Ridout, D.2
Nonis, C.3
Kooner, J.S.4
-
42
-
-
79251622270
-
Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: The CRIB-PHOS randomised controlled trial
-
Chue CD, Townend JN, Steeds RP, Ferro CJ: Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: The CRIB-PHOS randomised controlled trial. Trials 12: 30, 2011
-
(2011)
Trials
, vol.12
, pp. 30
-
-
Chue, C.D.1
Townend, J.N.2
Steeds, R.P.3
Ferro, C.J.4
-
43
-
-
0032944582
-
A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
-
Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rahman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E: A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33: 694-701, 1999 (Pubitemid 29159935)
-
(1999)
American Journal of Kidney Diseases
, vol.33
, Issue.4
, pp. 694-701
-
-
Bleyer, A.J.1
Burke, S.K.2
Dillon, M.3
Garrett, B.4
Kant, K.S.5
Lynch, D.6
Rahman, S.N.7
Schoenfeld, P.8
Teitelbaum, I.9
Zeig, S.10
Slatopolsky, E.11
-
44
-
-
0030806999
-
New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study
-
DOI 10.1016/S0021-9150(97)00106-8, PII S0021915097001068
-
Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study. Atherosclerosis 132: 245-250, 1997 (Pubitemid 27311017)
-
(1997)
Atherosclerosis
, vol.132
, Issue.2
, pp. 245-250
-
-
Kauppila, L.I.1
Polak, J.F.2
Cupples, L.A.3
Hannan, M.T.4
Kiel, D.P.5
Wilson, P.W.F.6
-
45
-
-
33745889016
-
Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance
-
Maceira AM, Prasad SK, Khan M, Pennell DJ: Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8: 417-426, 2006
-
(2006)
J Cardiovasc Magn Reson
, vol.8
, pp. 417-426
-
-
Maceira, A.M.1
Prasad, S.K.2
Khan, M.3
Pennell, D.J.4
-
46
-
-
0032527660
-
Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome
-
DOI 10.1016/S0002-9149(98)00315-4, PII S0002914998003154
-
Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE: Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 82: 203-208, 1998 (Pubitemid 28337732)
-
(1998)
American Journal of Cardiology
, vol.82
, Issue.2
, pp. 203-208
-
-
Groenink, M.1
De Roos, A.2
Mulder, B.J.M.3
Spaan, J.A.E.4
Van Der, W.E.E.5
-
47
-
-
0032408206
-
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis
-
DOI 10.1097/00004872-199816121-00033
-
Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16: 2079-2084, 1998 (Pubitemid 29002391)
-
(1998)
Journal of Hypertension
, vol.16
, Issue.12 SUPPL.
, pp. 2079-2084
-
-
Wilkinson, I.B.1
Fuchs, S.A.2
Jansen, I.M.3
Spratt, J.C.4
Murray, G.D.5
Cockcroft, J.R.6
Webb, D.J.7
-
48
-
-
29244432482
-
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
-
DOI 10.1016/j.echo.2005.10.005, PII S0894731705009831
-
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005 (Pubitemid 41821197)
-
(2005)
Journal of the American Society of Echocardiography
, vol.18
, Issue.12
, pp. 1440-1463
-
-
Lang, R.M.1
Bierig, M.2
Devereux, R.B.3
Flachskampf, F.A.4
Foster, E.5
Pellikka, P.A.6
Picard, M.H.7
Roman, M.J.8
Seward, J.9
Shanewise, J.S.10
Solomon, S.D.11
Spencer, K.T.12
St, J.S.M.13
Stewart, W.J.14
-
49
-
-
58849121949
-
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
-
Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22: 107-133, 2009
-
(2009)
J Am Soc Echocardiogr
, vol.22
, pp. 107-133
-
-
Nagueh, S.F.1
Appleton, C.P.2
Gillebert, T.C.3
Marino, P.N.4
Oh, J.K.5
Smiseth, O.A.6
Waggoner, A.D.7
Flachskampf, F.A.8
Pellikka, P.A.9
Evangelista, A.10
-
50
-
-
18744371012
-
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
-
DOI 10.1210/jc.2002-021105
-
Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S: Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87: 4957-4960, 2002 (Pubitemid 35316332)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.11
, pp. 4957-4960
-
-
Yamazaki, Y.1
Okazaki, R.2
Shibata, M.3
Hasegawa, Y.4
Satoh, K.5
Tajima, T.6
Takeuchi, Y.7
Fujita, T.8
Nakahara, K.9
Yamashita, T.10
Fukumoto, S.11
-
51
-
-
77955272026
-
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects
-
Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y: Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 398: 513-518, 2010
-
(2010)
Biochem Biophys Res Commun
, vol.398
, pp. 513-518
-
-
Yamazaki, Y.1
Imura, A.2
Urakawa, I.3
Shimada, T.4
Murakami, J.5
Aono, Y.6
Hasegawa, H.7
Yamashita, T.8
Nakatani, K.9
Saito, Y.10
Okamoto, N.11
Kurumatani, N.12
Namba, N.13
Kitaoka, T.14
Ozono, K.15
Sakai, T.16
Hataya, H.17
Ichikawa, S.18
Imel, E.A.19
Econs, M.J.20
Nabeshima, Y.21
more..
-
52
-
-
0032850868
-
Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: Implications for assessment of left ventricular dysfunction
-
DOI 10.1042/CS19990084
-
Downie PF, Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL: Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: Implications for assessment of left ventricular dysfunction. Clin Sci (Lond) 97: 255-258, 1999 (Pubitemid 29425318)
-
(1999)
Clinical Science
, vol.97
, Issue.3
, pp. 255-258
-
-
Downie, P.F.1
Talwar, S.2
Squire, I.B.3
Davies, J.E.4
Barnett, D.B.5
Ng, L.L.6
|